COMMUNIQUÉS West-GlobeNewswire

Xbrane and STADA enter into a co-development agreement for Xlucane
12/07/2018
Press release 2018-07-12 Xbrane Biopharma AB ("Xbrane") and STADA Arzneimittel AG ("STADA") have entered into a co-development agreement for Xlucane, a Lucentis ® (ranibizumab) biosimilar. About the agreement The [...]
NeuroMetrix, Inc. Announces Date for 2018 Second Quarter Financial Results Conference Call
12/07/2018
WALTHAM, Mass., July 12, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (NASDAQ:NURO) announced today that it plans to issue its 2018 second quarter financial results before the opening of the market on Thursday, July 19, [...]
Trinity Biotech plc to Announce Second Quarter Fiscal Year 2018 Financial Results
12/07/2018
Conference Call Scheduled for July 19, 2018 at 11:00 am EASTERN DUBLIN, Ireland, July 12, 2018 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the [...]
Medtronic Wins Expanded Indication for SelectSecure(TM) MRI SureScan(TM) Pacing Lead for His Bundle Site Stimulation
12/07/2018
DUBLIN - July 12, 2018 - Medtronic plc (NYSE:MDT) today announced U.S. Food and Drug Administration (FDA) labeling expansion for the Medtronic SelectSecure(TM) MRI SureScan(TM) Model 3830 cardiac pacing lead to include [...]
Cue Announces $30 Million Funding Contract from U.S. Department of Health and Human Services’ Biomedical Advanced Research and Development Authority
12/07/2018
SAN DIEGO, July 12, 2018 (GLOBE NEWSWIRE) -- Cue Health Inc. (“Cue”), a healthcare technology company, announced today that is has been awarded up to $30 million in base funding and options from the U.S. Department of [...]
CohBar Initiates Clinical Study with First-in-human Dosing of CB4211, a Novel Mitochondria Based Therapeutic for the Treatment of NASH
12/07/2018
MENLO PARK, Calif., July 12, 2018 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ:CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics (MBTs) to treat age-related diseases, today announced [...]
SELLAS Life Sciences Announces Pricing of Upsized $24.2 Million Public Offering
12/07/2018
NEW YORK, July 12, 2018 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) (“SELLAS” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of novel cancer [...]
Marrone Bio Innovations to Host Virtual Roadshow Webinar on July 26th, 2018
12/07/2018
DAVIS, Calif., July 12, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (the “Company” or “MBI”) (NASDAQ:MBII), a leading provider of bio-based pest management and plant health products for the agriculture, turf [...]
Cutera, Inc. to Announce Second Quarter 2018 Results
12/07/2018
BRISBANE, Calif., July 12, 2018 (GLOBE NEWSWIRE) -- Cutera, Inc. ( CUTR ) (“Cutera” or the “Company”), a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide, will announce [...]
Avinger Announces Pricing of $3.55 Million Registered Direct Offering
12/07/2018
REDWOOD CITY, Calif., July 12, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that it has entered into a [...]
Tauriga Sciences, Inc. on Track to Up-List its Shares to OTCQB Exchange at Open of Trading on July 30, 2018
12/07/2018
NEW YORK, NY, July 12, 2018 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTC PINK: TAUG) (OTC PINK: TAUGD) (“Tauriga” or the “Company”), engaged in building its business through the development, distribution, and [...]
WishBone Medical, Inc. announces Sanford S. Kunkel, M.D. joins Board of Advisors
12/07/2018
WARSAW, Ind., July 12, 2018 (GLOBE NEWSWIRE) -- WishBone Medical, Inc. is pleased to announce that Sanford Kunkel, M.D. joins the WishBone Medical Board of Advisors. Dr. Kunkel has been a Consulting Surgeon for WishBone [...]
Catalyst Biosciences Announces Multiple Presentations at the Scientific and Standardization Committee Meeting of the International Society on Thrombosis and Haemostasis
12/07/2018
Conference call and webcast to be held Wednesday, July 18, 2018 at 8:30 a.m. EDT SOUTH SAN FRANCISCO, Calif., July 12, 2018 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ:CBIO), a clinical-stage [...]
Altimmune Restructures Financing Agreement with Majority of the Remaining Series B Investors
12/07/2018
GAITHERSBURG, Md., July 12, 2018 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq:ALT), a clinical-stage immunotherapeutics company focused on preventing infectious diseases, today announced it has entered into agreements [...]
CLS Holdings USA Provides an Update to the First Complete Year of Adult Use Cannabis in Nevada
12/07/2018
Total Sales and Tax Revenue Higher than Initial Forecasts LAS VEGAS, July 12, 2018 (GLOBE NEWSWIRE) -- CLS Holdings USA, Inc. (OTCQB:CLSH) “CLS,” a diversified cannabis company operating as Cannabis Life Sciences and a [...]
Sirona Biochem Announces CFDA Approval of SGLT2 Inhibitor for Phase I Clinical Trial
12/07/2018
VANCOUVER, British Columbia, July 12, 2018 (GLOBE NEWSWIRE) -- Sirona Biochem Corp . (TSX-V:SBM) (FSE:ZSB) (the “ Company ”) announced today that partner, Jiangsu Wanbang Biopharmaceuticals (“Wanbang”), has confirmed [...]
Cue Biopharma Produces Immuno-STAT™ Biologic Candidate for Treatment of Autoimmune Disease Under Collaboration and License Agreement with Merck
12/07/2018
CAMBRIDGE, Mass., July 12, 2018 (GLOBE NEWSWIRE) -- Cue Biopharma , Inc., an immunotherapy company developing a novel, proprietary class of biologics engineered to selectively modulate the human immune system to treat [...]
HCi Viocare Rebrands Itself and Becomes Rafina Innovations Inc.
12/07/2018
Glasgow, Scotland, July 12, 2018 (GLOBE NEWSWIRE) -- HCi Viocare (OTCQB:VICA) , is pleased to announce that, further to our Current Report on Form 8-K filed June 15, 2018, HCi Viocare has completed a name change [...]
Managers' transactions
12/07/2018
Company Announcement No. 12/2018 12 July 2018 Attachment No 12 2018 US_Managers transactions

Pages